🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Arrhythmogenic Cardiomyopathies

Image-Based Prediction of Ventricular Tachycardia Events in Non-ischemic Cardiomyopathy NCT06730464n/a4 sites📍 Milan📍 Lispon📍 Barcelona Centro Medico Teknon Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC NCT06228924Phase 17 sites📍 San Francisco📍 Aurora📍 Baltimore Tenaya Therapeutics · Tests: TN-401 GEAM Study Aims At Assessing the Role of Genetic Testing in Patients with Arrhythmic Myocarditis. NCT06889662n/a1 site📍 Milan Scientific Institute San Raffaele A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM) NCT05885412Phase 13 sites📍 La Jolla📍 Durham📍 Philadelphia Rocket Pharmaceuticals Inc. · Tests: RP-A601 Left Atrial Appendage Arrhythmogenic and Thrombogenic Substrate NCT06405750NA1 site📍 Copenhagen University Hospital Bispebjerg and Frederiksberg · Tests: left atrial appendage closure DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies NCT04265040n/a1 site📍 Heidelberg University Hospital Heidelberg Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation NCT06813443n/a3 sites📍 Bologna📍 Roma📍 Florence IRCCS Azienda Ospedaliero-Universitaria di Bologna Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD NCT03593317Phase 213 sites📍 Amiens📍 Bron📍 Clermont-Ferrand Hospices Civils de Lyon · Tests: Spironolactone, Placebo Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management NCT04521790n/a1 site📍 Milan Scientific Institute San Raffaele · Tests: support treatment, cardiac medical treatment, aetiology-specific treatment, device implant, arrhythmia ablation Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy NCT06174220Phase 217 sites📍 Calgary📍 Vancouver📍 Victoria Hamilton Health Sciences Corporation · Tests: Tideglusib, Placebo Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition NCT06409585n/a1 site📍 Edinburgh University of Edinburgh · Tests: 68Ga-FAPI or 18F-AlF-FAPI cardiac PET-MR, Echocardiogram, Cardiac MRI A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM NCT06976606n/a6 sites📍 Redwood City📍 Baltimore📍 Columbia Lexeo Therapeutics National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter Registry NCT06546137n/a27 sites📍 Rio Branco📍 Maceió📍 Macapá Hospital do Coracao · Tests: whole genome sequencing Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH) NCT06922994Phase 25 sites📍 Pavia📍 Ancona📍 Milan Centro Cardiologico Monzino · Tests: Atorvastatin 80 mg/day, Placebo atorvastatin Cardiovascular Multimodality Imaging Study NCT06610019n/a1 site📍 The Bronx Montefiore Medical Center Mayo AVC Registry and Biobank NCT03049254n/a2 sites📍 Rochester📍 Papworth Everard Mayo Clinic Clinical Cohort Study - TRUST NCT05521451n/a1 site📍 Hamburg Universitätsklinikum Hamburg-Eppendorf Role of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management (MYOPED) NCT06591260n/a1 site📍 Milan Scientific Institute San Raffaele · Tests: support treatment, cardiac medical treatment, aetiology-specific treatment, device implant, arrhythmia ablation PKP2-ACM Natural History Study NCT06644742n/a3 sites📍 Boston📍 Durham📍 Amsterdam Rocket Pharmaceuticals Inc. Arrhythmogenic Activity During Exercise in ARVC Patients NCT06040242NA1 site📍 Zurich Swiss Federal Institute of Technology · Tests: Exercise Tissue and Metabolic Characterization of Arrhythmogenic Cardiomyopathies by Hybrid PET-MRI Imaging, Impact of the Observed Profiles on the Phenotype and on the Evolution of Cardiomyopathy NCT05450783n/a5 sites📍 Angers📍 Brest📍 Nantes Nantes University Hospital · Tests: Biocollection Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study. NCT06607471n/a1 site📍 Milan Scientific Institute San Raffaele · Tests: Support treatment, cardiac medical treatment, aetiology-specific treatment, device implant, arrhythmia ablation, Suppor… Subcutaneous Implantable Cardioverter-defibrillator (S-ICD) Eligibility Over Time in Arrhythmogenic Cardiomyopathy NCT07849764n/a1 site📍 São Paulo University of Sao Paulo · Tests: Subcutaneous ICD ECG screening The Application of T1 Mapping in Real-World NCT07354646n/a1 site📍 Beijing Chinese Academy of Medical Sciences, Fuwai Hospital · Tests: Magnetic Resonance Imaging with Contrast Pediatric Cardiomyopathy Mutation Analysis NCT02432092n/a1 site📍 Indianapolis Indiana University Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) NCT06311708n/a21 sites📍 San Francisco📍 Aurora📍 Baltimore Tenaya Therapeutics Risk Stratification, Early Prevention and Treatment Strategies for Arrhythmogenic Cardiomyopathy NCT06352307n/a1 site📍 Xi'an First Affiliated Hospital Xi'an Jiaotong University · Tests: Diagnosis of ACM Distribution of Cell-cell Junction Proteins in Arrhythmic Disorders NCT04257994n/a1 site📍 London St. George's Hospital, London · Tests: obtaining a buccal smear sample Local Inflammation in Arrhythmogenic Right Ventricular Cardiomyopathy NCT05209776NA1 site📍 Toulouse University Hospital, Toulouse · Tests: Peripheral immunological assessment on venous blood, Immunological assessment carried out on intracardiac material FAPI PET/CT Imaging in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) (FAPI-ARVC)) NCT07563660NA1 site📍 Istanbul Istanbul University - Cerrahpasa · Tests: 68Ga-DOTA-SA-FAPI PET/CT
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy